1. Home
  2. ATYR vs RMR Comparison

ATYR vs RMR Comparison

Compare ATYR & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.78

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo The RMR Group Inc.

RMR

The RMR Group Inc.

HOLD

Current Price

$15.74

Market Cap

253.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
RMR
Founded
2005
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
253.9M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
RMR
Price
$0.78
$15.74
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.6M
197.5K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
11.44%
EPS Growth
N/A
N/A
EPS
N/A
1.03
Revenue
$190,000.00
$196,824,000.00
Revenue This Year
N/A
$301.43
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$15.28
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$13.48
52 Week High
$7.29
$22.22

Technical Indicators

Market Signals
Indicator
ATYR
RMR
Relative Strength Index (RSI) 43.35 57.29
Support Level $0.70 $14.85
Resistance Level $0.83 $15.77
Average True Range (ATR) 0.06 0.36
MACD 0.03 0.05
Stochastic Oscillator 57.87 80.40

Price Performance

Historical Comparison
ATYR
RMR

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

Share on Social Networks: